ES2054626T3 - Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion. - Google Patents

Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion.

Info

Publication number
ES2054626T3
ES2054626T3 ES87103715T ES87103715T ES2054626T3 ES 2054626 T3 ES2054626 T3 ES 2054626T3 ES 87103715 T ES87103715 T ES 87103715T ES 87103715 T ES87103715 T ES 87103715T ES 2054626 T3 ES2054626 T3 ES 2054626T3
Authority
ES
Spain
Prior art keywords
formula
alkyl
salts
compound
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87103715T
Other languages
English (en)
Inventor
Takeshi Nakai
Fumiyuki Shirai
Toshiyuki Chiba
Hiroaki Ohtake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2054626T3 publication Critical patent/ES2054626T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un procedimiento para la preparación de derivados disustituidos en las posiciones 3,4 de la 2 -azetidinona de fórmula **fórmula** en la que: R1 es hidrógeno o un grupo protector del grupo imino, R2 es hidroxi-alquilo C1-C6 o hidroxi protegido-alquilo C1-C6, R3 es alquilo C1-C6, y R4 es 1-alquilo C1-C6-1-hidroxi-alquilo C2-C6, 1-alquilo C1-C6-1- hidroxi protegido - alquilo C2-C6 o 2-tioxotiazolidin-3-ilo, y sales de los mismos, que comprende: (1) hacer reaccionar un compuesto de fórmula **fórmula** en la que cada R1 y R2 son como se han definido anteriormente y R5 es acilo, o sales del mismo, con un compuesto de fórmula R3-CH2-CO-R4 en la que cada R3 y R4 son como se han definido anteriormente, o con sales del mismo, en presencia de un agente enolizante para dar un compuesto de fórmula **fórmula** en la que cada R1, R2, R3 y R4 son como se han definido anteriormente, o sales del mismo; y (2) someter un compuesto de fórmula **fórmula** en la que R1, R2 y R3 son, cada uno, como se han definidoanteriormente, y R4 a es 1 - alquilo C1-C6 - 1 -hidroxi protegido - alquilo C2-C6, o sales del mismo, a una reacción de separación del grupo protector del grupo hidroxi en R4a para dar un compuesto de fórmula **fórmula** en la que cada R1, R2 y R3 son como se han definido anteriormente, y R 4 b es 1 - alquilo C1-C6-1 -hidroxi - alquilo C2-C6, o sales del mismo; y (3) introducir un grupo protector del grupo imino en un compuesto de fórmula en la que cada R 2 , R 3 y R 4 son como se han definido anteriormente, o en sales del mismo, para dar un compuesto de fórmula **fórmula** en la que cada R2, R3 y R4 son como se han definido anteriormente y R 1 a es un grupo protector del grupo imino.
ES87103715T 1986-04-01 1987-03-14 Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion. Expired - Lifetime ES2054626T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607921A GB8607921D0 (en) 1986-04-01 1986-04-01 3,4-disubstituted-2-azetidinone derivatives

Publications (1)

Publication Number Publication Date
ES2054626T3 true ES2054626T3 (es) 1994-08-16

Family

ID=10595476

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87103715T Expired - Lifetime ES2054626T3 (es) 1986-04-01 1987-03-14 Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion.

Country Status (7)

Country Link
US (1) US5075437A (es)
EP (1) EP0239853B1 (es)
JP (1) JPS62246550A (es)
AT (1) ATE89561T1 (es)
DE (1) DE3785878T2 (es)
ES (1) ES2054626T3 (es)
GB (1) GB8607921D0 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2596979B2 (ja) * 1988-06-27 1997-04-02 三共株式会社 アゼチジノン誘導体の製造法
EP0364033A3 (en) * 1988-10-12 1991-10-09 Merck & Co. Inc. Stereoselective process for producing 1-beta-methylcarbapenem antibiotic intermediates
CZ285778B6 (cs) 1989-09-08 1999-11-17 Glaxo S.P.A. Kyselina 10-(1-hydroxyethyl)-11-oxo-1-azatricyklo/7,2,0,03,8/-undec-2en-2-karboxylová a její deriváty, způsob jejich výroby, použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem
GB9015485D0 (en) * 1990-07-13 1990-08-29 Glaxo Spa Heterocyclic derivatives
GB9103034D0 (en) * 1991-02-13 1991-03-27 Fujisawa Pharmaceutical Co Processes for preparing carbapenem derivatives
US5631363A (en) * 1992-11-13 1997-05-20 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
ATE242211T1 (de) * 1993-02-12 2003-06-15 Daiichi Suntory Pharma Co Ltd Verfahren zur synthese von 4-substituierten azetidinon-derivaten
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 4−置換アゼチジノン誘導体の製造方法
CA2732619A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
CN102093407B (zh) * 2011-01-26 2013-02-13 浙江新东港药业股份有限公司 碳青霉烯类抗生素中间体的制备方法
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge
CA1276156C (en) * 1985-03-29 1990-11-13 Thomas N. Salzmann Enantioselective process for producing 1-beta- methylcarbapenem antibiotic intermediates
JPS61275267A (ja) * 1985-03-29 1986-12-05 メルク エンド カムパニ− インコ−ポレ−テツド 1−β−メチルカルバペネム抗生物質中間体の鏡像異性選択的製造方法
CA1282415C (en) * 1985-08-31 1991-04-02 Yasuhiro Kuramoto Azetidin-2-on derivatives and process for production thereof
JPS62158277A (ja) * 1986-01-07 1987-07-14 Sumitomo Pharmaceut Co Ltd β−ラクタム誘導体

Also Published As

Publication number Publication date
GB8607921D0 (en) 1986-05-08
DE3785878D1 (de) 1993-06-24
ATE89561T1 (de) 1993-06-15
EP0239853B1 (en) 1993-05-19
US5075437A (en) 1991-12-24
EP0239853A1 (en) 1987-10-07
DE3785878T2 (de) 1993-09-09
JPS62246550A (ja) 1987-10-27

Similar Documents

Publication Publication Date Title
ES2054626T3 (es) Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion.
ES2058091T3 (es) Derivados de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico y procedimientos para su preparacion.
PT95870A (pt) Metodo para a preparacao de taxol que utiliza uma oxazinona
NO902404L (no) Fremgangsmaate for fremstilling av taxol, samt beta-laktamer for anvendelse som mellomprodukter ved fremgangsmaaten.
MY110249A (en) Method for preparation of taxol using beta lactam
AR012032A1 (es) Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
YU29085A (en) Process for obtaining of pyride-benzothiazine
ES387016A1 (es) Un procedimiento para la preparacion de derivado de isoqui-nolina.
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
AR002385A1 (es) Metodo para preparar ureas ciclicas n,n'-disustituidas a partir de diaminodioles lineales.
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
ES2040248T3 (es) Metodo de preparacion de derivados de inososa.
IL119696A0 (en) Optically active beta-aminoalcohols and process for their production
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
AR245940A1 (es) Procedimiento para obtener nuevos derivados del cromano.
ATE8884T1 (de) Cyclohexenderivate, verfahren zu ihrer herstellung und diese enthaltende fungizide.
GB1107732A (en) Amino-substituted benzoic acid lactones having estrogenic activity
ES2001006A4 (es) Compuestos sustituidos de 2,6-piridina sustituida
ES2094132T3 (es) Uso de derivados de xantina contra la ulcera peptica.
AR009349A1 (es) Un procedimiento para preparar paclitaxel, un derivado de taxano y un derivado de oxazolidina utilizables como intermediarios y procedimientos para prepararlos.
DE3161007D1 (en) Process for preparation of cycloalcoyl propanol amines useful as medicine
FR1261496A (fr) Procédé de préparation de n-arylurées substituées en n'
ES8201967A1 (es) Procedimiento para extraer y obtener acido tioglicolico de medios acuosos
GB2007977A (en) Treating plant viruses
FR1284194A (fr) Procédé de préparation d'un composé de blanchiment et de désinfection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 239853

Country of ref document: ES